Cost-effectiveness of adding empagliflozin to the standard of care for patients with heart failure with reduced ejection fraction from the perspective of healthcare system in Malaysia

Objective: The aim of this study was to determine the cost-effectiveness of adding empagliflozin to the standard of care versus SoC alone for the treatment of patients with heart failure (HF) with reduced ejection fraction (HFrEF) from the perspective of the Ministry of Health of Malaysia. Methods:...

Descripción completa

Detalles Bibliográficos
Autores principales: Ong, Siew Chin, Low, Joo Zheng, Linden, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277687/
https://www.ncbi.nlm.nih.gov/pubmed/37342587
http://dx.doi.org/10.3389/fphar.2023.1195124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277687/
https://www.ncbi.nlm.nih.gov/pubmed/37342587
http://dx.doi.org/10.3389/fphar.2023.1195124

Ejemplares similares